|
|
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)
Sébastien Gallien
,
Marie-Laure Chaix
,
El Mountacer El Abbassi
,
Christine Katlama
,
Nadia Valin
,
et al.
Journal articles
inserm-02096685v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genetically Intact but Functionally Impaired HIV-1 Env Glycoproteins in the T-Cell Reservoir
Anne de Verneuil
,
Julie Migraine
,
Fabrizio Mammano
,
Jean-Michel Molina
,
Sébastien Gallien
,
et al.
Journal articles
inserm-03451910v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS ‐165 DARULIGHT study
Minh Lê
,
Marie‐laure Chaix
,
François Raffi
,
Sylvie Chevret
,
Sébastien Gallien
,
et al.
Journal articles
hal-03639183v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era
Hugues Melliez
,
Murielle Mary-Krause
,
Marguerite Guiguet
,
Patrizia M. Carrieri
,
Sophie Abgrall
,
et al.
Journal articles
inserm-03104141v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France
Valérie Potard
,
Ana Canestri
,
Sébastien Gallien
,
Dominique Costagliola
Journal articles
hal-02447354v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ortho-proteogenomics: multiple proteomes investigation through orthology and a new MS-based protocol.
Sébastien Gallien
,
Emmanuel Perrodou
,
Christine Carapito
,
Caroline Deshayes
,
Jean-Marc Reyrat
,
et al.
Journal articles
inserm-00357410v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|